BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31602671)

  • 1. Chlorogenic acid activates ERK1/2 and inhibits proliferation of osteosarcoma cells.
    Sapio L; Salzillo A; Illiano M; Ragone A; Spina A; Chiosi E; Pacifico S; Catauro M; Naviglio S
    J Cell Physiol; 2020 Apr; 235(4):3741-3752. PubMed ID: 31602671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorogenic Acid Enhances Doxorubicin-Mediated Cytotoxic Effect in Osteosarcoma Cells.
    Salzillo A; Ragone A; Spina A; Naviglio S; Sapio L
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorogenic acid enhances the effects of 5-fluorouracil in human hepatocellular carcinoma cells through the inhibition of extracellular signal-regulated kinases.
    Yan Y; Li J; Han J; Hou N; Song Y; Dong L
    Anticancer Drugs; 2015 Jun; 26(5):540-6. PubMed ID: 25714249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-Adenosylmethionine Affects ERK1/2 and Stat3 Pathways and Induces Apotosis in Osteosarcoma Cells.
    Ilisso CP; Sapio L; Delle Cave D; Illiano M; Spina A; Cacciapuoti G; Naviglio S; Porcelli M
    J Cell Physiol; 2016 Feb; 231(2):428-35. PubMed ID: 26174106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
    Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of PARP-1 Inhibits Proliferation and ERK Signals, Increasing Drug Sensitivity in Osteosarcoma U2OS Cells.
    Li S; Cui Z; Meng X
    Oncol Res; 2016; 24(4):279-86. PubMed ID: 27656839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting inflammatory kinase as an adjuvant treatment for osteosarcomas.
    Noh K; Kim KO; Patel NR; Staples JR; Minematsu H; Nair K; Lee FY
    J Bone Joint Surg Am; 2011 Apr; 93(8):723-32. PubMed ID: 21508279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capsaicin inhibits proliferation and induces apoptosis in osteosarcoma cell lines via the mitogen‑activated protein kinase pathway.
    Zhang Y; Deng X; Lei T; Yu C; Wang Y; Zhao G; Luo X; Tang K; Quan Z; Jiang D
    Oncol Rep; 2017 Nov; 38(5):2685-2696. PubMed ID: 29048662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternol, a natural compound, exerts an anti-tumour effect on osteosarcoma by modulating of STAT3 and ROS/MAPK signalling pathways.
    Zuo D; Zhou Z; Wang H; Zhang T; Zang J; Yin F; Sun W; Chen J; Duan L; Xu J; Wang Z; Wang C; Lin B; Fu Z; Liao Y; Li S; Sun M; Hua Y; Zheng L; Cai Z
    J Cell Mol Med; 2017 Feb; 21(2):208-221. PubMed ID: 27624867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlorogenic Acid Inhibits Human Glioma U373 Cell Progression via Regulating the SRC/MAPKs Signal Pathway: Based on Network Pharmacology Analysis.
    Zhou J; Zhang F; Chen J; Zhang S; Wang H
    Drug Des Devel Ther; 2021; 15():1369-1383. PubMed ID: 33833498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlorogenic Acid Improves the Regorafenib Effects in Human Hepatocellular Carcinoma Cells.
    Refolo MG; Lippolis C; Carella N; Cavallini A; Messa C; D'Alessandro R
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29783729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlorogenic acid: A potent molecule that protects cardiomyocytes from TNF-α-induced injury via inhibiting NF-κB and JNK signals.
    Tian L; Su CP; Wang Q; Wu FJ; Bai R; Zhang HM; Liu JY; Lu WJ; Wang W; Lan F; Guo SZ
    J Cell Mol Med; 2019 Jul; 23(7):4666-4678. PubMed ID: 31033175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma.
    Oi T; Asanuma K; Matsumine A; Matsubara T; Nakamura T; Iino T; Asanuma Y; Goto M; Okuno K; Kakimoto T; Yada Y; Sudo A
    Int J Oncol; 2016 Dec; 49(6):2275-2284. PubMed ID: 27840900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Anthelmintic Drug Niclosamide Inhibits the Proliferative Activity of Human Osteosarcoma Cells by Targeting Multiple Signal Pathways.
    Liao Z; Nan G; Yan Z; Zeng L; Deng Y; Ye J; Zhang Z; Qiao M; Li R; Denduluri S; Wang J; Wei Q; Geng N; Zhao L; Lu S; Wang X; Zhou G; Luu HH; Haydon RC; He TC; Wang Z
    Curr Cancer Drug Targets; 2015; 15(8):726-38. PubMed ID: 26118906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlorogenic acid inhibits hepatocellular carcinoma in vitro and in vivo.
    Yan Y; Liu N; Hou N; Dong L; Li J
    J Nutr Biochem; 2017 Aug; 46():68-73. PubMed ID: 28458139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlorogenic acid inhibits hypoxia-induced pulmonary artery smooth muscle cells proliferation via c-Src and Shc/Grb2/ERK2 signaling pathway.
    Li QY; Zhu YF; Zhang M; Chen L; Zhang Z; Du YL; Ren GQ; Tang JM; Zhong MK; Shi XJ
    Eur J Pharmacol; 2015 Mar; 751():81-8. PubMed ID: 25666384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
    Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
    Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Elemene inhibits proliferation through crosstalk between glia maturation factor β and extracellular signal‑regulated kinase 1/2 and impairs drug resistance to temozolomide in glioblastoma cells.
    Zhu TZ; Li XM; Luo LH; Xu YH; Cao P; Liu Y; Liang GB
    Mol Med Rep; 2014 Aug; 10(2):1122-8. PubMed ID: 24866280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of PKC Binding and Translocation to Explain the Anticancer Mechanism of Chlorogenic Acid in Breast Cancer Cells.
    Deka SJ; Gorai S; Manna D; Trivedi V
    Curr Mol Med; 2017; 17(1):79-89. PubMed ID: 28190385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fisetin activates Hippo pathway and JNK/ERK/AP-1 signaling to inhibit proliferation and induce apoptosis of human osteosarcoma cells via ZAK overexpression.
    Fu CY; Chen MC; Tseng YS; Chen MC; Zhou Z; Yang JJ; Lin YM; Viswanadha VP; Wang G; Huang CY
    Environ Toxicol; 2019 Aug; 34(8):902-911. PubMed ID: 31044527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.